Different animal models reveal that inflammasome deficiency-associated changes in the gut microbiota composition were associated with exacerbated hepatic steatosis and inflammation through the influx of TLR4 and TLR9 agonists into the portal circulation. The gene discussed is TLR4; the disease is hyperinsulinemic hypoglycemia, familial, 4.